Protagenic Therapeutics Stock Forecast - Day Median Price
| PTIX Stock | USD 1.25 0.04 3.10% |
Protagenic Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Protagenic Therapeutics stock prices and determine the direction of Protagenic Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Protagenic Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Protagenic Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Protagenic Therapeutics' systematic risk associated with finding meaningful patterns of Protagenic Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Protagenic Therapeutics to cross-verify your projections. Protagenic |
Most investors in Protagenic Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Protagenic Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Protagenic Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Median Price is the statistical median of an asset price for a given trading period.| Previous Day Median Price | Day Median Price | Trend |
| 1.32 | 1.3 |
| Check Protagenic Therapeutics Volatility | Backtest Protagenic Therapeutics | Information Ratio |
Protagenic Therapeutics Trading Date Momentum
| On April 22 2024 Protagenic Therapeutics was traded for 1.25 at the closing time. The top price for the day was 1.34 and the lowest listed price was 1.25 . The trading volume for the day was 7.5 K. The trading history from April 22, 2024 did not cause price change. The trading delta at closing time against the current closing price is 3.20% . |
The median price is the midpoint of the trading periods range.
| Compare Protagenic Therapeutics to competition |
Other Forecasting Options for Protagenic Therapeutics
For every potential investor in Protagenic, whether a beginner or expert, Protagenic Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Protagenic Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Protagenic. Basic forecasting techniques help filter out the noise by identifying Protagenic Therapeutics' price trends.Protagenic Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Protagenic Therapeutics stock to make a market-neutral strategy. Peer analysis of Protagenic Therapeutics could also be used in its relative valuation, which is a method of valuing Protagenic Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Protagenic Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Protagenic Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Protagenic Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Protagenic Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Protagenic Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Protagenic Therapeutics shares will generate the highest return on investment. By undertsting and applying Protagenic Therapeutics stock market strength indicators, traders can identify Protagenic Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 505.95 | |||
| Daily Balance Of Power | (0.44) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 1.3 | |||
| Day Typical Price | 1.28 | |||
| Price Action Indicator | (0.07) | |||
| Period Momentum Indicator | (0.04) |
Protagenic Therapeutics Risk Indicators
The analysis of Protagenic Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Protagenic Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting protagenic stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.93 | |||
| Semi Deviation | 5.86 | |||
| Standard Deviation | 6.72 | |||
| Variance | 45.17 | |||
| Downside Variance | 53.49 | |||
| Semi Variance | 34.32 | |||
| Expected Short fall | (5.75) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Protagenic Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Protagenic Therapeutics' short interest history, or implied volatility extrapolated from Protagenic Therapeutics options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Protagenic Therapeutics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Historical Fundamental Analysis of Protagenic Therapeutics to cross-verify your projections. For more information on how to buy Protagenic Stock please use our How to Invest in Protagenic Therapeutics guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Protagenic Stock analysis
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Protagenic Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protagenic Therapeutics. If investors know Protagenic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protagenic Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Return On Assets (0.46) | Return On Equity (0.94) |
The market value of Protagenic Therapeutics is measured differently than its book value, which is the value of Protagenic that is recorded on the company's balance sheet. Investors also form their own opinion of Protagenic Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protagenic Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protagenic Therapeutics' market value can be influenced by many factors that don't directly affect Protagenic Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protagenic Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protagenic Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protagenic Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.